The rapid progression of CRISPR technology has sparked a vital dialogue around its ethical implications, inviting us to consider the morality of gene editing and its potential to cure diseases such as sickle cell.As scientists push the boundaries of genetic modification to alleviate suffering, critical questions arise about our responsibility to alter human genetics, especially when considering the societal impact on health equity.